NRIX
insider transactionsNurix Therapeutics, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 30d
-8.1K
0 buy · 8.1K sell
Net value · 30d
-$135.3K
$0 in · $135.3K out
Sentiment · 30d
Net selling
0% buying · 100% selling
Open-market trades · 30d
1
0 buy · 8.1K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Exercise·M
Chief Legal Officer · 10b5-1
$0
3.4K sh
Own +190%
-
Sell·S
Chief Legal Officer · 10b5-1
$135.3K
8.1K sh · $16.60
Own -38%
-
Exercise·M
Chief Legal Officer · 10b5-1
$6.4K
3.4K sh · $1.86
Own +19%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 2, 2026 | Christine Ring 10b5-1 | Exercise M | 3.4K | $0 |
| Jun 2, 2026 | Christine Ring 10b5-1 | Sell S | 8.1K | $135.3K |
| Jun 2, 2026 | Christine Ring 10b5-1 | Exercise M | 3.4K | $6.4K |
About NRIX insider trading
This page tracks insider transactions for Nurix Therapeutics, Inc. (NRIX) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.